by | Nov 11, 2024 | Uncategorized
Source: CureToday articles If approved by the FDA, Darzalex Faspro may be the first treatment for smoldering multiple myeloma as compared to treating the disease once it progresses. Read More
by | Nov 7, 2024 | Uncategorized
Source: CureToday articles In patients with relapsed or refractory multiple myeloma, KRd56 and KRd27 showed similar effectiveness and safety, but other treatment options may be better. Read More
by | Nov 5, 2024 | Uncategorized
Source: CureToday articles The CAR-T cell therapy Carvykti has been shown to be effective among patients outside the confines of a clinical trial. Read More
by | Nov 4, 2024 | Uncategorized
Inherited variants in DNA repair genes such as BRCA1 and BRCA2 may increase risk for multiple myeloma, according to results of a retrospective study.Patients with pathogenic germline variants exhibited increased likelihood of having a family or personal history of...
by | Oct 28, 2024 | Uncategorized
Decreasing the amount of dexamethasone that individuals with newly diagnosed multiple myeloma received did not affect survival, according to a secondary analysis of completed clinical trials.Nearly 70% of patients treated with dexamethasone required dose reductions...
by | Oct 24, 2024 | Uncategorized
The addition of daratumumab to maintenance lenalidomide extended PFS for patients who underwent stem cell transplant for newly diagnosed multiple myeloma, according to study results.The combination reduced risk for disease progression or death by 47% compared with...